Myriam Alvarez
Author ProfileClaim This Author Profile
Prove ownership by publishing #HashtagPLUS and this profile link on your author page or an article under your byline. A moderator or admin will review the request before it merges into your real HashtagPLUS username.
🌐 seekingalpha.comSource
From Seekingalpha RSS Feed: Pro-Dex: Still A Buy, But Don't Chase
🌐 seekingalpha.comSource
From Seekingalpha RSS Feed: Topicus Remains Exposed To AI, But Its Discount Is Compelling
🌐 seekingalpha.comSource
From Seekingalpha RSS Feed: Cytokinetics: Aficamten Has Momentum, But The Stock Is Too Expensive (Rating Downgrade)
🌐 seekingalpha.comSource
From Seekingalpha RSS Feed: Cerus Corporation: Strong Q1 Results Validate The Turnaround Thesis
🌐 seekingalpha.comSource
From Seekingalpha RSS Feed: Exodus Movement: Sensible Payments Strategy, But With Weakened Balance Sheet
🌐 seekingalpha.comSource
From Seekingalpha RSS Feed: Adlai Nortye: Recapitalized, Refocused, But Still Too Early To Upgrade
🌐 seekingalpha.comSource
From Seekingalpha RSS Feed: Roivant Sciences: Moderna Settlement And Brepocitinib Support A Long-Term Buy
🌐 seekingalpha.comSource
From Seekingalpha RSS Feed: Community Health Systems' Hospital Sales Strengthen Its Turnaround Story